An open-label study for the safety and efficacy of pomalidomide in refractory or refractory/relapsed multiple myeloma subjects

Update Il y a 4 ans
Reference: EUCTR2010-023343-16

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of pomalidomide (CC-4047) monotherapy in subjects with refractory or relapsed and refractory multiple myeloma who discontinued from Treatment Arm B (dexamethasone alone) of Study CC-4047-MM-003 due to the development of documented disease progression during treatment.


Inclusion criteria

  • Refractory or relapsed and refractory multiple myeloma